Tajima, N., Eiki, J., Okamoto, T., Okuyama, K., Kawashima, M., & Engel, S. S. (2019). Factors associated with the glucose‐lowering efficacy of sitagliptin in Japanese patients with type 2 diabetes mellitus: Pooled analysis of Japanese clinical trials. J Diabetes Investig.
Citação norma ChicagoTajima, Naoko, Jun‐ichi Eiki, Taro Okamoto, Kotoba Okuyama, Masaru Kawashima, and Samuel S. Engel. "Factors Associated With the Glucose‐lowering Efficacy of Sitagliptin in Japanese Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Japanese Clinical Trials." J Diabetes Investig 2019.
Citação norma MLATajima, Naoko, et al. "Factors Associated With the Glucose‐lowering Efficacy of Sitagliptin in Japanese Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Japanese Clinical Trials." J Diabetes Investig 2019.